Global Interventional Radiology Products Market Size study & Forecast, by Type (Stents, Catheters, IVC Filter, Biopsy Needles, Embolization Devices, Accessories), Procedure Type (Angioplasty, Angiography, Thrombolysis, Embolization), Applications (Oncolog

The Global Interventional Radiology Products Market, valued at approximately USD 12.37 billion in 2024, is poised to expand at a robust CAGR of 6.60% during the forecast period from 2025 to 2035. Interventional radiology products, which include an array of devices such as stents, catheters, embolization materials, and biopsy needles, are indispensable tools in minimally invasive diagnostic and therapeutic procedures. By combining cutting-edge imaging technologies with precision-engineered medical devices, healthcare providers can perform complex interventions with reduced recovery times, lower complication risks, and greater patient comfort. The market’s momentum is being propelled by the rising global burden of chronic diseases such as cancer, cardiovascular disorders, and peripheral artery disease, coupled with the ongoing transition toward outpatient and day-care surgical models. In parallel, rapid technological advancements in device design, imaging integration, and navigation systems are reshaping the clinical landscape, empowering physicians to treat conditions once considered inoperable.

With the surge in minimally invasive treatments, the demand for advanced interventional radiology solutions has escalated dramatically. These products are increasingly relied upon for oncology-related interventions, targeted drug delivery, and the precise removal of vascular obstructions. According to recent healthcare expenditure patterns, there has been a notable shift toward procedures that reduce hospital stays and improve patient throughput—an environment in which interventional radiology thrives. Emerging technologies such as AI-assisted imaging interpretation, 3D-printed anatomical models, and biocompatible materials are augmenting procedural accuracy and safety. Furthermore, the growing geriatric population, with its higher susceptibility to chronic conditions, is expected to further amplify market demand. Nevertheless, challenges such as high equipment costs, limited access to advanced imaging facilities in low-resource regions, and stringent regulatory pathways could temper growth over the long term.

From a geographical standpoint, North America commanded the largest share of the interventional radiology products market in 2025, benefiting from well-developed healthcare infrastructure, high procedural volumes, and continuous innovation from global medical technology leaders. Favorable reimbursement structures, an increasing emphasis on image-guided therapies, and the rapid adoption of AI-powered diagnostics also reinforce the region’s market dominance. Europe follows closely, supported by its strong network of specialized hospitals, well-trained interventional radiologists, and robust government healthcare funding. Meanwhile, the Asia Pacific region is forecast to witness the fastest growth rate through 2035, driven by rising healthcare investments, expanding hospital networks, and a surge in chronic disease cases in rapidly urbanizing nations such as China and India. Additionally, government-backed screening initiatives and the modernization of radiology departments are further fueling product uptake in APAC markets.

Major market player included in this report are:
• GE HealthCare Technologies Inc.
• Siemens Healthineers AG
• Boston Scientific Corporation
• Koninklijke Philips N.V.
• Cook Medical LLC
• Medtronic plc
• Canon Medical Systems Corporation
• Terumo Corporation
• Becton, Dickinson and Company
• Merit Medical Systems, Inc.
• Stryker Corporation
• Penumbra, Inc.
• AngioDynamics, Inc.
• Teleflex Incorporated
• Cordis Corporation

Global Interventional Radiology Products Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Type:
• Stents
• Catheters
• IVC Filter
• Biopsy Needles
• Embolization Devices
• Accessories

By Procedure Type:
• Angioplasty
• Angiography
• Thrombolysis
• Embolization

By Applications:
• Oncology

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more